As of 2026-07-15, the Relative Valuation of Deciphera Pharmaceuticals Inc (DCPH) is (46.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.59 USD, the upside of Deciphera Pharmaceuticals Inc based on Relative Valuation is -280.7%.
The range of the Relative Valuation is (42.94) - (49.32) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 24.6x | 21.0x |
| Forward P/E multiples | 19.5x - 22.4x | 21.0x |
| Fair Price | (42.94) - (49.32) | (46.24) |
| Upside | -267.8% - -292.7% | -280.7% |
| Date | P/E |